E-Novia Logo

E-Novia

A venture studio and consultancy that transforms Physical AI research into products.

E9IA | XMIL

Overview

Corporate Details

ISIN(s):
IT0005391229
LEI:
815600080AB1FC472040
Country:
Italy
Address:
VIA SAN MARTINO, 12, 20122 MILANO

Description

E-Novia is a venture studio and innovation consultancy that specializes in Physical AI. The company transforms technological research and ideas into market-ready products and scalable enterprises, bridging the gap between academic research and industrial application. Its process covers the entire innovation lifecycle, from market research and concept design to engineering, prototyping, and venture building. E-Novia develops intelligent solutions that interact with the physical world through sensors, algorithms, and embedded systems. The firm's portfolio includes ventures in sectors such as mobility, industrial automation, and smart infrastructure, creating products like sensorized bolts for structural monitoring, adaptive suspension systems for vehicles, and autonomous delivery robots.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-03 19:41
PUBBLICATO L’AVVISO DI CONVOCAZIONE DELL’ASSEMBLEA STRAORDINARIA DEGLI AZIONISTI
Italian 282.5 KB
2025-10-02 16:46
ISCRITTI NEL REGISTRO DELLE IMPRESE I VERBALI DELLE ADUNANZE RELATIVE AL PROGET…
Italian 239.0 KB
2025-09-30 19:45
AVVISO DI PUBBLICAZIONE DELLA RELAZIONE FINANZIARIA SEMESTRALE CONSOLIDATA AL 3…
Italian 678.4 KB
2025-09-26 20:02
IL CONSIGLIO DI AMMINISTRAZIONE APPROVA LA RELAZIONE FINANZIARIA CONSOLIDATA AL…
Italian 1.1 MB
2025-08-05 21:09
APPROVAZIONE DELLE MODIFICHE DEL REGOLAMENTO DEL PRESTITO OBBLIGAZIONARIO DENOM…
Italian 292.3 KB
2025-08-01 12:31
ISCRIZIONE NEL REGISTRO DELLE IMPRESE DEL PROGETTO DI FUSIONE PER INCORPORAZION…
Italian 250.2 KB
2025-07-31 08:05
DEPOSITO PROGETTO DI FUSIONE PER INCORPORAZIONE DI ESION S.R.L., EXISTO S.R.L. …
Italian 276.5 KB
2025-07-28 19:38
IL GRUPPO E-NOVIA SEMPLIFICA LA STRUTTURA SOCIETARIA: FUSIONE PER INCORPORAZION…
Italian 284.7 KB
2025-07-28 19:35
NOMINATO VITTORIO AVOGADRO DI COLLOBIANO COME NUOVO CONSIGLIERE
Italian 259.5 KB
2025-07-12 10:16
Pubblicato l'Avviso di Convocazione dell'Assemblea Ordinaria degli Azionisti
Italian 293.8 KB
2025-07-10 20:37
CONVOCAZIONE DELL’ASSEMBLEA ORDINARIA DEGLI AZIONISTI
Italian 244.6 KB
2025-06-30 18:34
E-NOVIA: L’ASSEMBLEA ORDINARIA DEGLI AZIONISTI APPROVA IL BILANCIO AL 31 DICEMB…
Italian 259.0 KB
2025-06-20 10:48
AVVISO DI CORTESIA RELATIVO ALL’ASSEMBLEA DEGLI AZIONISTI
Italian 242.1 KB
2025-06-12 21:33
RELAZIONE DELLA SOCIETA’ DI REVISIONE SUL BILANCIO DI ESERCIZIO E SUL BILANCIO …
Italian 1.8 MB
2025-06-12 21:32
PUBBLICATO L’AVVISO DI CONVOCAZIONE DELL’ASSEMBLEA ORDINARIA DEGLI AZIONISTI
Italian 292.2 KB

Automate Your Workflow. Get a real-time feed of all E-Novia filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for E-Novia

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for E-Novia via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Transgene Logo
Develops cancer immunotherapies using vaccines and oncolytic viruses.
France
TNG
TRANS GENIC GROUP INC. Logo
Biotech firm offering drug discovery support and investment/consulting services.
Japan
2342
TriSalus Life Sciences, Inc. Logo
Oncology company integrating drug delivery with immunotherapy to treat solid tumors.
United States of America
TLSI
TScan Therapeutics, Inc. Logo
A clinical-stage biotech developing TCR-engineered T cell therapies for cancer.
United States of America
TCRX
Tsubota Laboratory Incorporated Logo
R&D company developing treatments for ophthalmology and CNS disorders.
Japan
4890
TuHURA Biosciences, Inc./NV Logo
A Phase 3 immuno-oncology company developing therapies for immunotherapy resistance.
United States of America
HURA
Tyra Biosciences, Inc. Logo
Clinical-stage biotech developing precision medicines targeting FGFR biology.
United States of America
TYRA
UCAR Logo
A nonprofit consortium of universities advancing atmospheric and Earth system sciences.
France
ALUCR
Ulisse Biomed Logo
Develops an integrated platform for distributed and connected diagnostic solutions.
Italy
UBM
UNIVERSAL DISPLAY CORP \PA\ Logo
Researches, develops, and supplies OLED technologies and materials for displays.
United States of America
OLED

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.